Development and validation of a high-throughput method for the quantitative analysis of felodipine in human plasma using high-performance liquid chromatography with mass/mass spectrometer and its application to a bioequivalence study in healthy male Korean subjects

[1]  R. Alonso,et al.  Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples. , 2006, Forensic science international.

[2]  G. De Nucci,et al.  Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  W. Weinmann,et al.  Screening for dihydropyridine calcium channel blockers in plasma by automated solid-phase extraction and liquid chromatography/tandem mass spectrometry. , 2004, Journal of mass spectrometry : JMS.

[4]  R. Watts,et al.  Clinical equivalence of two tablet formulations of felodipine , 1995, European Journal of Clinical Pharmacology.

[5]  N. Benowitz,et al.  Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects , 2004, European Journal of Clinical Pharmacology.

[6]  Hoo-Kyun Choi,et al.  Bioequivalence of Stapin ER Tablet to Splendil ER Tablet (Felodipine 5 mg) , 2003 .

[7]  M. Ahnoff,et al.  Enantioselective determination of felodipine in human plasma by chiral normal-phase liquid chromatography and electrospray ionisation mass spectrometry. , 2002, Journal of pharmaceutical and biomedical analysis.

[8]  R. Pieri,et al.  Antihypertensive effects of six calcium antagonists: evidence from Fourier analysis of 24-hour ambulatory blood pressure recordings , 2001 .

[9]  F. Messerli,et al.  Cardiac effects of calcium antagonists in systemic hypertension. , 1997, The American journal of cardiology.

[10]  G. Nyberg,et al.  Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers , 1997, European Journal of Clinical Pharmacology.

[11]  D. Faulds,et al.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. , 1992, Drugs.

[12]  B. Edgar,et al.  Bioavailability from felodipine extended-release tablets with different dissolution properties , 1990 .

[13]  B. Edgar,et al.  Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets. , 1990, British journal of clinical pharmacology.

[14]  D. Breimer,et al.  Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma. , 1990, Journal of chromatography.

[15]  C. Regårdh,et al.  Pharmacokinetics of felodipine in patients with impaired renal function. , 1989, British journal of clinical pharmacology.

[16]  C. Regårdh,et al.  Clinical pharmacokinetics of felodipine. A summary. , 1987, Drugs.

[17]  C. Regårdh,et al.  Felodipine kinetics in healthy men , 1985, Clinical pharmacology and therapeutics.

[18]  L. Weidolf.  Bimodal column switching liquid chromatographic assay of six metabolites of [14C] felodipine in rat urine. , 1985, Journal of chromatography.

[19]  M. Ahnoff.  Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. , 1984, Journal of pharmaceutical and biomedical analysis.